» Authors » Stephanie M Pouch

Stephanie M Pouch

Explore the profile of Stephanie M Pouch including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 438
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Beechar V, Phadke V, Pouch S, Woodworth M
Transpl Infect Dis . 2024 Jan; 26(2):e14245. PMID: 38291882
Cytomegalovirus (CMV) infections are a major source of morbidity and mortality in solid organ transplant recipients. Prophylactic, preemptive, and hybrid prevention strategies have traditionally been the mainstay of CMV prevention...
12.
Beechar V, Pouch S, Phadke V, Karadkhele G, Larsen C, Woodworth M
Transpl Infect Dis . 2023 Dec; 26(1):e14219. PMID: 38158932
Background: Cytomegalovirus (CMV) infection has broad implications for morbidity and mortality in renal transplant recipients (RTR). Routine surveillance for CMV replication with PCR-based quantitative nucleic acid testing (qNAT) assays is...
13.
Saharia K, Hall V, Chesdachai S, Porrett P, Fishman J, Pouch S
Transpl Infect Dis . 2023 Dec; 26(1):e14206. PMID: 38055610
In this clinicopathological conference, invited experts discussed a previously published case of a patient with nonischemic cardiomyopathy who underwent heart transplantation from a genetically modified pig source animal. His complex...
14.
Rowe S, Green S, Albrecht B, Pouch S
Open Forum Infect Dis . 2023 Nov; 10(11):ofad537. PMID: 38023541
Background: Infection is the leading cause of morbidity and mortality in patients with left ventricular assist devices (LVADs). Prolonged suppressive therapy should be strongly considered and is often used in...
15.
Woodworth M, Conrad R, Haldopoulos M, Pouch S, Babiker A, Mehta A, et al.
Sci Transl Med . 2023 Nov; 15(720):eabo2750. PMID: 37910603
Multidrug-resistant organism (MDRO) colonization is a fundamental challenge in antimicrobial resistance. Limited studies have shown that fecal microbiota transplantation (FMT) can reduce MDRO colonization, but its mechanisms are poorly understood....
16.
Franci E, Adekunle R, Nucci M, Pouch S
Transpl Infect Dis . 2023 Jun; 25(4):e14079. PMID: 37279241
This case describes a 42-year-old man who underwent kidney transplantation and developed fevers, pancytopenia, and elevated liver function tests starting on post-operative day 9. An extensive microbiologic and molecular workup...
17.
Eichenberger E, Satola S, Neujahr D, Fowler Jr V, Gupta D, Ford M, et al.
Clin Transplant . 2023 May; 37(9):e15038. PMID: 37229554
Background: Little is understood about the risk factors and outcomes from candidemia in thoracic solid organ transplant recipients. Methods: This is a single-center retrospective cohort study of patients undergoing heart...
18.
Booker S, Jett C, Fox C, Anesi J, Berry G, Dunn K, et al.
Transpl Infect Dis . 2023 Mar; 25(3):e14048. PMID: 36864666
No abstract available.
19.
Boutin C, Pouch S, Ison M
Transpl Infect Dis . 2023 Feb; 25(2):e14032. PMID: 36748658
Deceased donor and organ perfusion fluid cultures are obtained in order to inform recipient antimicrobial management and therefore reduce the risk of donor-derived bacterial and fungal infections. However, important heterogeneity...
20.
Goldman J, Pouch S, Woolley A, Booker S, Jett C, Fox C, et al.
Transpl Infect Dis . 2023 Jan; 25(1):e14013. PMID: 36694448
Background: Decisions to transplant organs from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid test-positive (NAT+) donors must balance risk of donor-derived transmission events (DDTE) with the scarcity of...